The UMCG website shows YouTube videos. YouTube places cookies if you watch them. Choose ‘Rather not’ if you do not want these cookies. We also place cookies of our own. These help us improve the usability of our website.
More on our cookie policy.
In a study led by Lilu Ding and Truuske de Bock of the University Medical Center Groningen, a validated micro-simulation model was applied to evaluate the overdiagnosis of invasive breast cancer. The follow-up time of screening varied from 2 to 15 years and the screening start age varied from 50 to 68 years.
The researchers found that the chance of overdiagnosis of invasive breast cancer is less than 1 in 1000 when screened every two years until 69 years. Overdiagnosis decreased with longer follow-up time and stabilised at 10 years. Overdiagnosis for women at age 68 was nearly three times higher than at age 50.
Earlier studies found up to 54% overdiagnosis of invasive breast cancer, without distinction to age. We show that these high estimates are mainly due to a very short follow-up time. Our results show that an accurate estimate of overdiagnosis requires at least 10 years of follow-up. Moreover, the risk of overdiagnosis is larger for older than for younger women.
The researchers published the results of their study in the European Journal of Cancer:
Overdiagnosis of invasive breast cancer in population-based breast cancer screening: A short- and long-term perspective - ScienceDirect